Hin Sang Group (International) Holding Co. Ltd. (Main Board of Hong Kong, China, Stock Code: 06893) is a health-focused, technology-driven conglomerate operating a comprehensive health industry chain. Rooted in the profound wisdom of "medicine and food homology" and precision nutrition, the company leverages cutting-edge technological innovations to establish a complete industrial ecosystem spanning from "source research and development" to "health intervention" and "ecological services."

Under the philosophy of "selecting natural ingredients and nurturing health through herbal nourishment," the group has dedicated nearly 20 years to developing infant vitamins, nutritional supplements, and adult health products. Its product lines are distributed across Mainland China, Hong Kong, Macau, Taiwan, and Southeast Asia. The company has maintained its position as the No.1 children’s vitamins and nutritional supplements in Hong Kong for 15 consecutive years and has consistently upheld its reputation as a leading expert in infant health products.

Starting in 2025, Hin Sang Group has been actively expanding its presence in the health culture, technology, and ecological industry chains. By promoting the health preservation culture, the company aims to become a global benchmark for the integration of technology and health within the broader health industry. Through "smart hardware + AI data + precision products + ecological services," it is committed to providing premium health technology products rooted in the principles of medicine and food homology to customers worldwide.